These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 28206724)
21. Association of catalase gene polymorphisms with catalase activity and susceptibility to systemic lupus erythematosus in the Suez Canal area, Egypt. Ghaly MS; Ghattas MH; Labib SM Lupus; 2012 Oct; 21(11):1244-9. PubMed ID: 22736749 [TBL] [Abstract][Full Text] [Related]
22. Involvement of superoxide dismutase isoenzymes and their genetic variants in progression of and higher susceptibility to vitiligo. Laddha NC; Dwivedi M; Gani AR; Shajil EM; Begum R Free Radic Biol Med; 2013 Dec; 65():1110-1125. PubMed ID: 24036105 [TBL] [Abstract][Full Text] [Related]
23. Association of elevated homocysteine levels and Methylenetetrahydrofolate reductase (MTHFR) 1298 A > C polymorphism with Vitiligo susceptibility in Gujarat. Jadeja SD; Mansuri MS; Singh M; Patel H; Marfatia YS; Begum R J Dermatol Sci; 2018 May; 90(2):112-122. PubMed ID: 29395581 [TBL] [Abstract][Full Text] [Related]
24. Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo. Imran M; Laddha NC; Dwivedi M; Mansuri MS; Singh J; Rani R; Gokhale RS; Sharma VK; Marfatia YS; Begum R Br J Dermatol; 2012 Aug; 167(2):314-23. PubMed ID: 22512783 [TBL] [Abstract][Full Text] [Related]
25. The association between endothelin-1 gene polymorphisms and susceptibility to vitiligo in a Korean population. Kim HJ; Choi CP; Uhm YK; Kim YI; Lee JW; Yoon SH; Chung JH; Lee MH Exp Dermatol; 2007 Jul; 16(7):561-6. PubMed ID: 17576235 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of the correlation between serum levels of vitamin D and vitamin D receptor gene polymorphisms in an Egyptian population. Sobeih S; Mashaly HM; Gawdat H; Amr K; Hamid MF; Shaalan E Int J Dermatol; 2016 Dec; 55(12):1329-1335. PubMed ID: 27420410 [TBL] [Abstract][Full Text] [Related]
27. The combination of tumour necrosis factor-α -308A and interleukin-10 -1082G gene polymorphisms and increased serum levels of related cytokines: susceptibility to vitiligo. Aydıngöz IE; Kanmaz-Özer M; Gedikbaşi A; Vural P; Doğru-Abbasoğlu S; Uysal M Clin Exp Dermatol; 2015 Jan; 40(1):71-7. PubMed ID: 25283497 [TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with vitiligo. Al-Harthi F; Zouman A; Arfin M; Tariq M; Al-Asmari A Genet Mol Res; 2013 Jul; 12(3):2196-204. PubMed ID: 23884763 [TBL] [Abstract][Full Text] [Related]
29. Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population. Dwivedi M; Laddha NC; Mansuri MS; Marfatia YS; Begum R Br J Dermatol; 2013 Nov; 169(5):1114-25. PubMed ID: 23773036 [TBL] [Abstract][Full Text] [Related]
30. Inducible nitric oxide synthase promoter polymorphism: a molecular susceptibility marker for vitiligo in Egyptians. Zayed AA; Khorshied MM; Hussein MF Int J Dermatol; 2015 Jun; 54(6):675-9. PubMed ID: 25556582 [TBL] [Abstract][Full Text] [Related]
31. Association of estrogen receptor 1 intron 1 C/T polymorphism in Korean vitiligo patients. Jin SY; Park HH; Li GZ; Lee HJ; Hong MS; Park HJ; Park HK; Seo JC; Yim SV; Chung JH; Lee MH J Dermatol Sci; 2004 Sep; 35(3):181-6. PubMed ID: 15381239 [TBL] [Abstract][Full Text] [Related]
32. A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat. Jadeja SD; Mansuri MS; Singh M; Dwivedi M; Laddha NC; Begum R PLoS One; 2017; 12(7):e0180958. PubMed ID: 28700671 [TBL] [Abstract][Full Text] [Related]
33. Human catalase, its polymorphisms, regulation and changes of its activity in different diseases. Kodydková J; Vávrová L; Kocík M; Žák A Folia Biol (Praha); 2014; 60(4):153-67. PubMed ID: 25152049 [TBL] [Abstract][Full Text] [Related]
34. Association of FOXP3 (rs3761548) promoter polymorphism with nondermatomal vitiligo: A study from India. Jahan P; Cheruvu R; Tippisetty S; Komaravalli PL; Valluri V; Ishaq M J Am Acad Dermatol; 2013 Aug; 69(2):262-6. PubMed ID: 23498308 [TBL] [Abstract][Full Text] [Related]
35. TLR2 and TLR4 gene polymorphisms in Turkish vitiligo patients. Karaca N; Ozturk G; Gerceker BT; Turkmen M; Berdeli A J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e85-90. PubMed ID: 22429552 [TBL] [Abstract][Full Text] [Related]
36. Association of the CAT-262C>T polymorphism with asthma in smokers and the nonemphysematous phenotype of chronic obstructive pulmonary disease. Taniguchi N; Konno S; Isada A; Hattori T; Kimura H; Shimizu K; Maeda Y; Makita H; Hizawa N; Nishimura M Ann Allergy Asthma Immunol; 2014 Jul; 113(1):31-36.e2. PubMed ID: 24824229 [TBL] [Abstract][Full Text] [Related]
37. Association of Angiotensin-Converting Enzyme (ACE) Gene Polymorphism with Inflammation and Cellular Cytotoxicity in Vitiligo Patients. Rashed L; Abdel Hay R; Mahmoud R; Hasan N; Zahra A; Fayez S PLoS One; 2015; 10(7):e0132915. PubMed ID: 26177100 [TBL] [Abstract][Full Text] [Related]
38. Association of GZMB polymorphisms and susceptibility to non-segmental vitiligo in a Korean population. Jeong KH; Kim SK; Seo JK; Shin MK; Lee MH Sci Rep; 2021 Jan; 11(1):397. PubMed ID: 33431938 [TBL] [Abstract][Full Text] [Related]
39. Possible contribution of GSTP1 and other xenobiotic metabolizing genes to vitiligo susceptibility. Minashkin MM; Salnikova LE; Lomonosov KM; Korobko IV; Tatarenko AO Arch Dermatol Res; 2013 Apr; 305(3):233-9. PubMed ID: 23179585 [TBL] [Abstract][Full Text] [Related]
40. Association of interferon-gamma and tumor necrosis factor alpha polymorphisms with susceptibility to vitiligo in Iranian patients. Namian AM; Shahbaz S; Salmanpoor R; Namazi MR; Dehghani F; Kamali-Sarvestani E Arch Dermatol Res; 2009 Jan; 301(1):21-5. PubMed ID: 18820938 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]